中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | JN929010 |
|---|---|
| 説明 |
InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) [Iv0202] (JN929010) is a alpaca monoclonal antibody detecting Protein glycosylation K in ELISA, Neutralization.
|
| 種反応性 | Campylobacter jejuni |
| アプリケーション | ELISA, Neutralization |
| 宿主種 | Alpaca |
| クローン性 | Monoclonal |
| アイソタイプ | VHH-8His-Cys-tag |
| クローンID | Iv0202 |
| ターゲット | Protein glycosylation K, 7.5.2.5, pglK, wlaB, Cj1130c |
| エンドトキシンレベル | <0.01 EU/ug |
| 純度 | >95% as determined by SDS-PAGE. |
| 関連製品 | pH 7.4 Dilution Buffer |
| 精製 | Purified by Nickel column. |
| アクセッション番号 | Q0P9C4 |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS pH 7.4 データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 背景 | Protein glycosylation K (wlaB/pglK) is a ~64 kDa protein. Mediates the ATP-dependent translocation of the undecaprenylpyrophosphate-linked heptasaccharide intermediate across the cell membrane; this is an essential step during the N-linked protein glycosylation pathway. Transport across the membrane is effected via ATP-driven conformation changes. Most likely, only the polar and charged part of the glycolipid enter the substrate-binding cavity, and the lipid tail remains exposed to the membrane lipids during the transmembrane flipping process. |
| 注意事項 | For research use only. Not suitable for clinical or therapeutic use. |
SDS-PAGE for InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
